THE BENEFITS OF PSYCHEDELIC THERAPY FOR MENTAL HEALTH: EXPLORING PSYCHEDELICS
Zenodo (CERN European Organization for Nuclear Research) May 13, 2022 Liliana Irizabal
A systematic review of published research indicates that psychedelic psychotherapy can reduce symptoms of depression, anxiety, and PTSD. Psilocybin and ayahuasca (DMT) were associated with decreased anxiety and depression when administered in specific doses. MDMA was associated with reduced PTSD symptoms. The authors note that research is limited and more studies are needed, but the existing evidence shows promising results.